Algernon Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended February 29, 2024. For the second quarter, the company reported net loss was CAD 1 million compared to CAD 1.25 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.13 a year ago.
For the six months, net loss was CAD 1.53 million compared to CAD 3.13 million a year ago. Basic loss per share from continuing operations was CAD 0.09 compared to CAD 0.33 a year ago.